ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions

View by Date

Sunday, November 8, 2020

5:00PM-5:50PM: Abstract Number: 1504

Four Distinct Symptom-Based Clusters Identified from the Sjӧgren’s Foundation Survey

Sjögren’s Syndrome (1502–1506)

5:00PM-5:50PM: Abstract Number: 1519

Interleukin-17D, a Cytokine Derived from Stromal Cells, Attenuates Joint Inflammation

Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1517–1521)

5:00PM-5:50PM: Abstract Number: 1517

Metabolic Regulation of Type 3 Innate Lymphoid Cells by Intestinal Bacteria-Derived Indoles in Ankylosing Spondylitis

Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1517–1521)

5:00PM-5:50PM: Abstract Number: 1490

Pain Rating Variability and Response to Treatment in Osteoarthritis Clinical Trials

Osteoarthritis II: Clinical Aspects (1487–1491)

5:00PM-5:50PM: Abstract Number: 1475

Predictors of Thirty-Day Hospital Readmissions in Systemic Lupus Erythematosus in the US: A Nationwide Study

Epidemiology & Public Health III: Risk Factors & Outcomes (1472–1476)

5:00PM-5:50PM: Abstract Number: 1489

Relation of Pain Mechanisms to Development of Knee Pain in Osteoarthritis: The Multicenter Osteoarthritis Study

Osteoarthritis II: Clinical Aspects (1487–1491)

5:00PM-5:50PM: Abstract Number: 1518

The Role for Neutrophils in the Early Phases of Enthesitis in Spondyloarthritis

Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1517–1521)

5:00PM-5:50PM: Abstract Number: 1476

Trends in Mortality and Cause-specific Mortality Among Patients with Psoriasis and Psoriatic Arthritis in Ontario, Canada

Epidemiology & Public Health III: Risk Factors & Outcomes (1472–1476)

5:00PM-5:50PM: Abstract Number: 1503

Ultra High‐resolution Ultrasound (UHFUS) of Labial Salivary Glands Might Help to Avoid Unnecessary Lip Biopsy in Patients with Sicca Syndrome

Sjögren’s Syndrome (1502–1506)

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].